Endovenous laser ablation (EVLA), radio frequency (RF), foam sclerotherapy and stripping for treatment of varicose veins

A randomised controlled trial of endovenous laser ablation (EVLA), radio frequency (RF), foam sclerotherapy and stripping for treatment of varicose veins

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN08060326

Enrollment

500

Registered

2009-08-27

Start date

2007-01-01

Completion date

Unknown

Last updated

2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose veins Circulatory System Varicose veins of other sites

Interventions

1. Surgery: high ligation and stripping plus stab phlebectomies 2. Endovenous laser ablation plus phlebectomies 3. Radiofrequency ablation plus phlebectomies

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Varicose veins due to greater saphenous vein (GSV) insufficiency 2. Aged greater than or equal to 18 years, to an upper limit of 75 years, either sex

Exclusion criteria

Exclusion criteria: Aged below 18 and above 75 years

Design outcomes

Primary

Measure	Time frame
Recurrent varicose veins after surgery (REVAS), measured at baseline, 1 month, 12 months, yearly thereafter for a total of 5 years.	—

Secondary

Measure	Time frame
Measured at baseline, 1 month, 12 months, yearly thereafter for a total of 5 years: 1. Quality of life 2. Varicose vein severity score (VVSS)	—

Countries

Denmark

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026